Disruption of the interaction of α-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter

Biochemistry

Volumn 44, Issue 41, 2005, Pages 13612-13624

  Wersinger, Christophe ^a   Sidhu, Anita ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; COMPLEXATION; DEPOLYMERIZATION; DISEASES; MINES; PROTEINS;

DEPOLYMERIZATION AGENTS; DOPAMINE; NEGATIVE MODULATION; PARKINSON'S DISEASE;

MUTAGENESIS;

ALPHA SYNUCLEIN; ALPHA TUBULIN; BETA TUBULIN; COLCHICINE; COMPLEMENTARY DNA; DOPAMINE; DOPAMINE TRANSPORTER; NOCODAZOLE; TRITIUM; VINBLASTINE;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; FIBROBLAST CULTURE; IMMUNOPRECIPITATION; MESENCEPHALON; MICROTUBULE; MOUSE; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; WESTERN BLOTTING;

ALPHA-SYNUCLEIN; ANIMALS; CELL LINE; CELLS, CULTURED; COLCHICINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; KINETICS; MALE; MICE; MICROTUBULES; NOCODAZOLE; RATS; SUBSTANTIA NIGRA; TRANSFECTION; TUBULIN; VINBLASTINE;

EID: 26644462144     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi050402p     Document Type: Article

References (59)

1. Spillantini, M. G., and Goedert, M. (2000) The α-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, Ann. N.Y. Acad. Sci. 920, 16-27.
2. Maries, E., Dass, B., Collier, T. J., Kordower, J. H., and Steece-Collier, K. (2003) The role of α-synuclein in Parkinson's disease: Insights from animal models, Nat. Rev. Neurosci. 4, 727-738.
3. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di lorio, G., Golbe, L. I., and Nussbaum, R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease, Science 276, 2045-2047.
4. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. T., Schols, L., and Riess, O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease, Nat. Genet. 18, 106-108.
5. Sidhu, A., Wersinger, C., and Vernier, P. (2004) Does α-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J. 18, 637-647.
6. Sidhu, A., Wersinger, C., and Vernier, P. (2004) α-Synuclein regulation of the dopaminergic transporter: A possible role in the pathogenesis of Parkinson's disease, FEBS Lett. 565, 1-5.
7. Wersinger, C., and Sidhu, A. (2003) Attenuation of dopamine transporter activity by α-synuclein, Neurosci. Lett. 340, 189-192.
8. Wersinger, C., Prou, D., Vernier, P., and Sidhu, A. (2003) Modulation of dopamine transporter function by α-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress, FASEB J. 17, 2151-2153.
9. Wersinger, C., Vernier, P., and Sidhu, A. (2004) Trypsin disrupts the trafficking of the human dopamine transporter by α-synuclein and its A30P mutant, Biochemistry 43, 1242-1253.
10. - neurotransmitter transporters, J. Neurochem. 71, 1785-1803.
11. Gainetdinov, R. R., and Caron, M. G. (2003) Monoamine transporters: From genes to behavior, Annu. Rev. Pharmacol. Toxicol. 43, 261-284.
12. Pristupa, Z. B., McConkey, F., Liu, F., Man, H. Y., Lee, F. J., Wang, Y. T., and Niznik, H. B. (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter, Synapse 30, 79-87.
13. Melikian, H. E., and Buckley, K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter, J. Neurosci. 19, 7699-7710.
14. Daniels, G. M., and Amara, S. G. (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters, J. Biol. Chem. 274, 35794-35801.
15. --dependent neurotransmitter transporters: Drugs, substrates, presynaptic receptors, and signaling systems, Pharmacol. Ther. 92, 21-55.
16. Wilson, L., Panda, D., and Jordan, M. A. (1999) Modulation of microtubule dynamics by drugs: A paradigm for the actions of cellular regulators, Cell Struct. Funct. 24, 329-335.
17. Gai, W. P., Power, J. H. T., Blumbergs, P. C., Culvenor, J. G., and Jensen, P. H. (1999) α-Synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components, J. Neurochem. 73, 2093-2100.
18. D'Andrea, M. R., Ilyin, S., and Plata-Salaman, C. R. (2001) Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues, Neurosci. Lett. 306, 137-142.
19. Payton, J. E., Perrin, R. J., Clayton, D. F., and George, J. M. (2001) Protein-protein interactions of α-synuclein in brain homogenates and transfected cells, Brain Res. Mol. Brain Res. 95, 138-145.
20. Lee, V. M., Giasson, B. I., and Trojanowski, J. Q. (2004) More than just two peas in a pod: Common amyloidogenic properties of tau and α-synuclein in neurodegenerative diseases, Trends Neurosci. 27, 129-134.
21. Alim, M. A., Hossain, M. S., Arima, K., Takeda, K., Izumiyama, Y., Nakamura, M., Kaji, H., Shinoda, T., Hisanaga, S., and Ueda, K. (2002) Tubulin seeds α-synuclein fibril formation, J. Biol. Chem. 277, 2112-2117.
22. Jensen, P. H., Hojrup, P., Hager, H., Nielsen, M. S., Jacobsen, L., Olesen, O. F., Gliemann, J., and Jakes, R. (1999) α-Synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356, J. Biol. Chem. 274, 25481-25489.
23. Jensen, P. H., Islam, K., Kenney, J., Nielsen, M. S., Power, J., and Gai, W. P. (2000) Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds α-synuclein filaments, J. Biol. Chem. 275, 21500-21507.
24. Sharma, N., Hewett, J., Ozelius, L. J., Ramesh, V., McLean, P. J., Breakefield, X. O., and Hyman, B. T. (2001) A close association of torsinA and α-synuclein in Lewy bodies: A fluorescence resonance energy transfer study, Am. J. Pathol. 159, 339-344.
25. Alim, M. A., Ma, Q. L., Takeda, K., Aizawa, T., Matsubara, M., Nakamura, M., Asada, A., Saito, T., Kaji, H., Yoshii, M., Hisanaga, S., and Ueda, K. (2004) Demonstration of a role for α-synuclein as a functional microtubule-associated protein, J. Alzheimer's Dis. 6, 435-449.
26. Clayton, D. F., and George, J. M. (1999) Synucleins in synaptic plasticity and neurodegenerative disorders, J. Neurosci. Res. 58, 120-129.
27. George, J. M. (2002) The synucleins, Genome Biol. 3, 1-6.
28. Lotharius, J., and Brundin, P. (2002) Pathogenesis of Parkinson's disease: Dopamine, vesicles and α-synuclein, Nat. Rev. Neurosci. 3, 932-942.
29. Goodno, C. C. (1982) Myosin active-site trapping with vanadate ion, Methods Enzymol. 85, 116-123.
30. 51V NMR study of vanadate binding to myosin and its subfragment 1, Biochemistry 29 (38), 9091-9096.
31. Chen, J., Wersinger, C., and Sidhu, A. (2003) Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity, J. Biol. Chem. 278, 28089-28100.
32. Wersinger, C., Prou, D., Vernier, P., Niznik, H. B., and Sidhu, A. (2003) Mutations in the lipid-binding domain of α-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity, Mol. Cell. Neurosci. 24, 91-105.
33. Lee, F. J., Liu, F., Pristupa, Z. B., and Niznik, H. B. (2001) Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis, FASEB J. 15, 916-926.
34. Minotti, A. M., Barlow, S. B., and Cabral, F. (1991) Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin, J. Biol. Chem. 266 (6), 3987-3994.
35. Giannakakou, P., Sackett, D. L., Ward, Y., Webster, K. R., Blagosklonny, M. V., and Fojo, T. (2000) p53 is associated with cellular microtubules and is transported to the nucleus by dynein, Nat. Cell Biol. 2, 709-717.
36. Poruchynsky, M. S., Kim, J. H., Nogales, E., Annable, T., Loganzo, F., Greenberger, L. M., Sackett, D. L., and Fojo, T. (2004) Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in α- or β-tubulin and increased microtubule stability, Biochemistry 43, 13944-13954.
37. Gupta, K., Bishop, J., Peck, A., Brown, J., Wilson, L., and Panda, D. (2004) Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin, Biochemistry 43, 6645-6655.
38. Wersinger, C., Banta, M., and Sidhu, A. (2004) Comparative analyses of α-synuclein expression levels in rat brain tissues and transfected cells, Neurosci. Lett. 358, 95-98.
39. Arima, K., Hirai, S., Sunohara, N., Aoto, K., Izumiyama, Y., Ueda, K., Ikeda, K., and Kawai, M. (1999) Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies, Brain Res. 843, 53-61.
40. Conway, K. A., Rochet, J. C., Bieganski, R. M., and Lansbury, P. T., Jr. (2001) Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct, Science 294, 1346-1349.
41. Li, J., Zhu, M., Manning-Bog, A. B., Di Monte, D. A., and Fink, A. L. (2004) Dopamine and L-dopa disaggregate amyloid fibrils: Implications for Parkinson's and Alzheimer's disease, FASEB J. 18, 962-964.
42. Ingram, A. J., James, L., Cai, L., Thai, K., Ly, H., and Scholey, J. W. (2000) NO inhibits stretch-induced MAPK activity by cytoskeletal disruption, J. Biol. Chem. 275, 40301-40306.
43. Banan, A., Fields, J. Z., Decker, H., Zhang, Y., and Keshavarzian, A. (2000) Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction, J. Pharmacol. Exp. Ther. 294, 997-1008.
44. Song, X., and Ehrich, M. (1998) Alterations of cytoskeletal tau protein of SH-SY5Y human neuroblastoma cells after exposure to MPTP, Neurotoxicology 19, 73-81.
45. De Girolamo, L. A., Billett, E. E., and Hargreaves, A. J. (2000) Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on differentiating mouse N2a neuroblastoma cells, J. Neurochem. 75, 133-140.
46. Cappelletti, G., Camatini, M., Brambilla, E., and Maci, R. (1991) N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces cytoskeletal alterations on 'Swiss 3T3' mouse fibroblasts, Neurosci. Lett. 129, 149-152.
47. + in vitro, Cell Biol. Int. 25, 981-984.
48. Loktionova, S. A., and Kabakov, A. E. (1998) Protein phosphatase inhibitors and heat preconditioning prevent Hsp27 dephosphorylation, F-actin disruption and deterioration of morphology in ATP-depleted endothelial cells, FEBS Lett. 433, 294-300.
49. Song, X., Perkins, S., Jortner, B. S., and Ehrich, M. (1997) Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells, Neurotoxicology 18, 341-353.
50. Urani, C., Brambilla, E., Santagostino, A., and Camatini, M. (1994) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects the actin cytoskeleton and calcium level of Swiss 3T3 mouse fibroblasts, Toxicology 91, 117-126.
51. + neurotoxicity on NGF-differentiated PC12 cells, Cell Biol. Int. 19, 687-693.
52. Przedborski, S., Chen, Q., Vila, M., Giasson, B. I., Djaldatti, R., Vukosavic, S., Souza, J. M., Jackson-Lewis, V., Lee, V. M., and Ischiropoulos, H. (2001) Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease, J. Neurochem. 76, 637-640.
53. Araki, T., Muramatsu, Y., Tanaka, K., Matsubara, M., and Imai, Y. (2001) Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice, Neurosci. Lett. 312, 50-54.
54. Yamin, G., Uversky, V. N., and Fink, A. L. (2003) Nitration inhibits fibrillation of human α-synuclein in vitro by formation of soluble oligomers, FEBS Lett. 542, 147-152.
55. Dauer, W., Kholodilov, N., Vila, M., Trillat, A. C., Goodchild, R., Larsen, K. E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C. A., Rocha, M., Jackson-Lewis, V., Hersch, S., Sulzer, D., Przedborski, S., Burke, R., and Hen, R. (2002) Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP, Proc. Natl. Acad. Sci. U.S.A. 99, 14524-14529.
56. Robertson, D. C., Schmidt, O., Ninkina, N., Jones, P. A., Skarkey, J., and Buchman, V. L. (2004) Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ-synuclein, α-synuclein and double α/γ-synuclein null mutant mice, J. Neurochem. 89, 1126-1136.
57. Goedert, M. (2001) α-Synuclein and neurodegenerative diseases, Nat. Rev. Neurosci. 2, 492-501.
58. Jakes, R., Spillantini, M. G., and Goedert, M. (1994) Identification of two distinct synucleins from human brain, FEBS Lett. 345, 27-32.
59. Buchman, V. L., Hunter, H. J., Pinon, L. G., Thompson, J., Privalova, E. M., Ninkina, N. N., and Davies, A. M. (1998) Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system, J. Neurosci. 18, 9335-9341.